The endocycle is a variant cell cycle consisting of successive DNA synthesis and gap phases that yield highly polyploid cells. Although essential for metazoan development, relatively little is known about its control or physiologic role in mammals. Using lineage-specific cre mice we identified two opposing arms of the E2F program, one driven by canonical transcription activation (E2F1, E2F2 and E2F3) and the other by atypical repression (E2F7 and E2F8), that converge on the regulation of endocycles in vivo. Ablation of canonical activators in the two endocycling tissues of mammals, trophoblast giant cells in the placenta and hepatocytes in the liver, augmented genome ploidy, whereas ablation of atypical repressors diminished ploidy. These two antagonistic arms coordinate the expression of a unique G2/M transcriptional program that is critical for mitosis, karyokinesis and cytokinesis. These results provide in vivo evidence for a direct role of E2F family members in regulating non-traditional cell cycles in mammals.
The archetypal cell division cycle culminates in the generation of genetically identical diploid progenies. However, a number of cell-cycle variations in nature exist, with the endocycle being a remarkable variant used by a wide range of organisms in diverse environmental contexts 1 . This modified cell cycle is characterized by alternating DNA synthesis (S) and gap (G) phases in the absence of intervening mitosis (M), karyokinesis and cytokinesis. As a result of successive rounds of whole-genome duplication, cells may achieve genome polyploidy that exceeds 1000C (refs 2,3) . The biological advantages of polyploidy have been proposed to include an augmented response to strenuous cellular metabolic demands; dampened sensitivity to apoptotic or checkpoint stimuli 4 ; and buffering against deleterious mutations that may cause cancer 5, 6 . The molecular mechanisms that control mitotic and variant cell cycles among species are presumed to be similar. In the textbook view single DBD, heterodimerize with DP1/DP2 proteins and associate with chromatin-modifying proteins to repress gene expression 18 . The most recently identified family members encode the atypical repressors E2F7 and E2F8, which have two tandem DBDs and repress gene expression independent of DP1/DP2 heterodimerization 19 . Whereas flies and plants use endocycles as a mechanism for cell growth in a variety of tissue types 1, 20 , endocycles in mammals are mainly restricted to trophoblast giant cells (TGCs) in the placenta and hepatocytes in the liver 1, 5 . Endocycles in these mammalian tissues are believed to be integral to organ physiology 1, 5 ; however, surprisingly little evidence exists to support this contention. Here we developed new genetic tools in mice and show by depletion of either canonical E2F activators or atypical E2F repressors that these two separate E2F transcriptional programs converge to control the endocycle through the regulation of cellular events important for mitosis, karyokinesis and cytokinesis. Surprisingly, placentae and livers with severely restricted polyploidization retained sufficient physiological function to carry them through apparently normal development.
RESULTS

E2f1-3 ablation results in hyperploidy
E2F-mediated transcription contributes to endocycle control in flies and plants 1, 5, [19] [20] [21] , but its role in mammals has not been thoroughly evaluated. Whole-genome duplication in mammalian endocycling cells is temporally regulated during development with major ploidy increases in TGCs during mid gestation and in hepatocytes following weaning at around three weeks of age 22, 23 . The levels of E2f1 and E2f2 messenger RNAs in laser-capture-microdissected TGCs from wild-type placentae, as measured by NanoString technology (Fig. 1a) , were low throughout placental development, whereas the level of E2f3 mRNA was high before embryonic day (E)8.5 and following E13.5. Expression analysis in livers by quantitative real-time polymerase chain reaction (rtPCR) showed relatively high levels of E2f1 and E2f2 during fetal development and a precipitous decrease following birth (postnatal day 0, P0), whereas expression of E2f3 (E2f3a and E2f3b) decreased gradually following birth and was almost undetectable post-weaning (Fig. 1b) . Consistent with the expression pattern of their mRNAs, E2F3a and E2F3b protein levels decreased in newborn pups post-weaning ( Supplementary Fig. S1a ), and E2F1 and E2F2 proteins could not be detected beyond the intrauterine period (data not shown). Thus, it seems that total E2F1-3 activator levels are minimized when TGCs and hepatocytes are most actively endocycling.
We used targeted gene inactivation strategies in mice to rigorously evaluate the role of E2F activators in endocycling TGCs and hepatocytes. To avoid functional compensation 24 , we evaluated TGCs in embryos deficient for the entire E2F activator subclass (E2f1-3).
Visual inspection of haematoxylin and eosin (H&E)-stained E9.5 E2f1
−/− ;E2f2 −/− ;E2f3 −/− (123tko) placentae revealed the presence of TGCs with abnormally large nuclei (Fig. 1c) . Feulgen staining and quantification of genome ploidy by standardized methods ( Supplementary Fig. S1b ) showed a shift of the 123tko TGC population towards higher ploidy ( Fig. 1d and Supplementary Fig. S1c ). Analysis of 123tko TGCs at later stages of development was precluded owing to embryo lethality at E10. 5 (refs 25,26) .
To evaluate the role of the three activator E2Fs in hepatocytes we used polyinosine-polycytidine (pIpC)-inducible Mx-cre mice 27 and conditional alleles of E2f3 (Mx-cre;E2f1 −/− ;E2f2 −/− ;E2f3 f / f ; Mx123tko) to examine the consequences of their combined ablation. Injection of pIpC in six-week-old Mx-123tko mice resulted in increased liver weights (Fig. 1f ) and proportionately larger hepatocytes (Fig. 1e,f ) than age-matched controls. Loss of E2f1 alone or in combination with E2f2 and E2f3 resulted in a gene-dose-dependent increase in hepatocyte ploidy ( Fig. 1g and Supplementary Fig. S1d ). The expression of E2f repressors (E2f4-8) was not affected by loss of E2f1-3 ( Supplementary  Fig. S1e ). Together, these findings suggest that mammalian E2F activators have a physiologic role in suppressing endocycles.
E2f7/E2f8 ablation reduces TGC ploidy
Next, we explored the role of E2F repressors in endocycle control. Expression analysis of the canonical repressors (E2f4-6 ) showed relatively high levels of E2f4 in TGCs of E6.5 placentae that decreased with time, whereas E2f5-6 expression was relatively constant throughout placental development (Fig. 2a, left panel) ; expression of E2f4-6 was relatively high in fetal livers and their expression decreased after birth ( Supplementary Fig. S2a ). Inspection of E2f4 −/− or E2f5 −/− embryos and mice revealed normal placentae and livers ( Supplementary Fig. S2b,c) ; E2f6 −/− placentae and livers were not evaluated.
We then focused our attention on the atypical repressors, E2F7 and E2F8. These E2Fs are expressed in TGCs throughout placental development (Fig. 2a, right panel) . Immunohistochemistry showed robust staining of E2F7 and E2F8 proteins in a portion of TGCs (Fig. 2b , arrows), consistent with their established cell-cycle-dependent expression in late S and G2 phases [28] [29] [30] [31] . Visual inspection of E2f7 −/− ;E2f8 −/− placentae at E10.5, one day before their embryonic lethality 16 , revealed a surprising number of TGCs at various stages of mitosis (Fig. 2c) , implying an interruption of normal endocycles. Indeed, the ploidy of E2f7 −/− ;E2f8 −/− TGCs never exceeded 64C (Fig. 2d , black bars), whereas wild-type TGCs with genomes >1,000C were readily detected (Fig. 2d, white bars) . The combined inactivation of E2f7 and E2f8 led to ectopic bromodeoxyuridine (BrdU) incorporation (Fig. 2e,g ), increased levels of G2/M (cyclin A2) and M-phase-specific proteins (cyclin B1 and phosphorylated H3, P-H3; Fig. 2f,g ) and the appearance of numerous TGCs in metaphase and anaphase (Fig. 2h) . Confocal microscopy and three-dimensional (3D) reconstruction of serially imaged E2f7 −/− ;E2f8 −/− placentae showed that approximately 40% of TGCs contained at least two nuclei (Fig. 2i) , which was confirmed by transmission electron microscopy (Fig. 2j) Fig. 2d and Supplementary  Fig. S2d ,e) and a proportionate increase in G2/M-and M-phase-related events (Fig. 2g,j) , once again suggesting a gene dosage effect.
As the expression of trophoblast cell lineage markers was altered in placentae globally deleted for E2f7 and E2f8 (TGCs, labyrinth trophoblasts and spongiotrophoblasts) 32 , we could not formally rule out a general disruption of differentiation as a possible cause for the endocycle defects observed in mutant TGCs. To specifically ablate E2f7 and E2f8 in TGCs of placentae we crossed Plf cre/+ knock-in mice ( Fig. 2k and data not shown) 32 with E2f7 f /f ; E2f8 f / f mice to yield Plf-78dko embryos. We confirmed the TGC-specific ablation of conditional alleles by PCR genotyping of laser-capture-microdissected samples (Fig. 2l) . The same abnormalities were observed in Plf78dko TGCs as in E2f7
; E2f8 −/− TGCs, including the reduced ploidy, increased cyclin A2, cyclin B1 and P-H3 expression levels, and ectopic karyokinesis (Fig. 2d,g,j; red bars). In summary, these data demonstrate cell autonomous functions for E2F7 and E2F8 in facilitating TGC endocycles by repressing key molecular events required for mitosis and karyokinesis.
E2f7/E2f8 ablation prevents hepatocyte endocycles
The expression of E2f7 and E2f8 in fetal livers was high but decreased to almost undetectable levels by weaning age ( Fig. 3b and Fig. S3b ). However, evaluation of H&E-and 4 ,6-diamidino-2-phenylindole (DAPI)-stained liver sections from Alb-8ko and Alb-78dko mice revealed markedly smaller hepatocytes with smaller nuclei than in control animals ( Fig. 3a,c) . This reduction in cell size was compensated by an increase in the total number of hepatocytes (Fig. 3d) . Moreover, Alb-8ko and Alb-78dko livers had a decreased proportion of binucleated hepatocytes (Fig. 3e) , which is an early event believed to precede the onset of polyploidization 34 . Strikingly, flow cytometry showed that hepatocytes in Alb-8ko and Alb-78dko livers remained diploid over the entire lifetime of the mouse, whereas hepatocytes in Alb-7ko livers had only a modest reduction in genome ploidy (Fig. 3f) . The percentages of Ki67-, cyclin-A2-, cyclin-B1-and P-H3-positive hepatocytes were significantly elevated in 2-month-old Alb-8ko mice and even more so in similarly aged Alb-78dko mice (Fig. 3g) . Analysis of mice globally deleted for E2f7 (E2f7 −/− ) or E2f8 (E2f8 −/− ) yielded identical phenotypes as conditionally deleted Alb-7ko and Alb-8ko mice ( Supplementary Fig.  S3c,d) . Surprisingly, Alb-78dko mice survived to old age in apparent good health and retained the capacity to regenerate their livers on chemical (carbon tetrachloride) or physical (partial hepatectomy) injury ( Supplementary Fig. S3e -h and data not shown). From these results, we conclude that E2F8 is the principal atypical E2F that functions to promote hepatocyte endocycles in mice.
The onset of genome endoreduplication in hepatocytes coincides with the weaning of pups, but DNA content continues to increase through adulthood even though very little E2f8 is expressed at this time (see Fig. 3b ). These observations raised the possibility that E2F8 might be required only for the programmed onset and not the continuation of endocycles. We thus used a tamoxifen-inducible system (SA-creER T2 ) to express cre in hepatocytes following birth or following the weaning of pups 35 . As determined by quantitative rtPCR, 
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E2F7/E2F8 regulate endocycle-related genes
Given the role of E2F7 and E2F8 in transcriptional repression, we anticipated changes in gene expression as the principal underlying cause for the observed endocycle defects in E2f7/E2f8-deficient tissues. Gene expression profiling (Affymetrix Mouse Genome 430 2.0) using RNA purified from livers of 3-week-old wild-type, Alb-7ko, Alb-8ko and Alb-78dko mice showed that there were significantly more upregulated than downregulated genes in mutant tissues, consistent with their roles as repressors (Fig. 4a) . Expression changes were confirmed by NanoString technology (Supplementary Fig. S5a ). Supervised clustering methods identified three main classes of differentially expressed genes (Fig. 4a) . Class I includes genes differentially expressed in all three mutant genetic groups relative to wild-type controls. These genes may represent targets regulated by both E2F7 and E2F8 because loss of either member led to their derepression. Class II represents genes differentially expressed in two of the three mutant genetic groups and includes target genes that may be uniquely repressed by either E2F7 or E2F8. Finally, class III represents genes differentially expressed in only one mutant genetic group, and includes target genes that may be synergistically repressed by E2F7 and E2F8. Cell-cell signal. Further analysis focused on genes upregulated in both Alb-8ko and Alb-78dko livers (Class II), as hepatocytes in these two genetic groups exhibited the most pronounced reduction in genome ploidy, as well as genes upregulated in all three mutant cohorts (in Class I), because these could also contribute to the observed defect in polyploidization. Closer inspection of these genes by Ingenuity Pathway Analysis revealed a striking bias for functions related to cytokinesis, G2/M progression and various stages of mitosis, such as chromosome condensation, stabilization and segregation ( Supplementary Fig. S5b,c) . By manual annotation we also noted an increase in gene products with GTPase-activating (GAP) or GTP exchange factor (GEF) functions (data not shown), which regulate the Rho family of small GTPases essential for successful cytokinesis 36 . NanoString technology was then used to interrogate the expression of a panel of genes with cell-cycle-and G2/M-related functions in TGCs from E10.5 wild-type, E2f7 −/− , E2f8 −/− and E2f7 −/− ;E2f8 −/− placentae. As shown in Fig. 4b , 66 of the 99 genes interrogated had predominantly increased expression in E2f7/E2f8-deficient TGCs, suggesting a common mechanism for how E2F7 and E2F8 may regulate endocycles in TGCs and hepatocytes.
A significant portion of common upregulated genes in E2f7/E2f8-deficient TGCs and hepatocytes have E2F-binding elements on their promoters, raising the possibility that these may represent direct targets of E2F7/E2F8. To test this hypothesis, we transfected human HepG2 cells and rat Rcho-1 trophoblast stem cells with plasmids expressing Flag-tagged E2F7 or E2F8 and performed chromatin immunoprecipitation (ChIP) assays with anti-Flag antibodies. As shown in Fig. 5b,d , Flag-specific antibodies, but not control IgG, co-immunoprecipitated promoter sequences containing E2F-binding elements, but not irrelevant sequences lacking E2F-binding sites (Tub). The above results were corroborated by further ChIP assays in human embryonic kidney (HEK) 293 cells transfected with either Flag-tagged E2F7 or E2F7 (Supplementary Fig. S5d ) and in wild-type liver tissues transfected by hydrodynamic-based methods with plasmids expressing Flag-tagged E2F8 (Fig. 5e,f) . Together, these results suggest that E2F7 and E2F8 repress a core group of genes with prominent involvement in the regulation of G2/M-related events.
E2F1 functionally opposes atypical E2F7/E2F8
Given that ablation of E2f1-3 and E2f7/E2f8 led to opposite effects on hepatocyte ploidy, we explored the possibility of cross-regulation Fig. 6f. a- −/− ;E2f7 f / f ;E2f8 f / f . Data in b,c,e-h reported as average ± s.d. b,f one-way ANOVA, * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.001. c,e,g,h two-tailed Student t -test, * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.001. Scale bars, 12.5 µm (a) and 10 µm (d).
between these two E2F subclasses. Loss of E2f1-3 did not impact the expression of other E2Fs (E2f4-8; see Supplementary Fig. S1e) ; however, loss of E2f7/E2f8 resulted in a transient increase of E2f1 expression soon after birth in the liver (Supplementary Fig. S5e) . Interestingly, loss of E2f7/E2f8 had no significant effect on the expression of E2f1-6 in TGCs (Supplementary Fig. S5f ). We then profiled global gene expression in hepatocytes lacking the three E2F activators (Mx-123tko). Strikingly, this analysis showed that most genes upregulated in E2f7/E2f8-deficient hepatocytes were downregulated in E2f1-3-deficient hepatocytes (Fig. 4c) , and many of these genes had annotated cell-cycle functions related to G2/M transitions or mitoses and had E2F-binding sites in their promoters ( Fig. 4d and Supplementary Fig. S5g,h) .
On the basis of the above results we considered the hypothesis that canonical E2F activators may functionally antagonize atypical E2F repressors in the control of endocycles. To rigorously test this possibility we generated and analysed mice with TGCs or hepatocytes deficient for E2F7, E2F8 and E2F1 (E2f1 −/− ). (Fig. 6a) , with some TGCs having 128C and 256C genomes (Fig. 6b) , which was never observed in Plf-78dko TGCs. This increase in ploidy was accompanied by a significant decrease in the number of multinucleated TGCs and a slight decrease in BrdU-and P-H3-positive cells, even though the number of cyclin-A2-positive TGCs was not reduced (Fig. 6c) . Similar results were obtained when placentae globally deleted for E2f1, E2f7 and E2f8 (178tko) were examined ( Supplementary Fig. S6a-c) . Evaluation of Alb-178tko livers revealed larger hepatocytes containing greater DNA content than in Alb-78dko livers, with some reaching 8C ploidy (Fig. 6d-f) . The Alb-178tko livers also had many more binucleated hepatocytes (Fig. 6g) , and importantly, had fewer Ki67-, P-H3-and cyclin-B1-positive hepatocytes, even though again, the percentage of cyclin-A2-positive cells was not reduced (Fig. 6h) . Thus, it seems that loss of E2f1 suppressed some, but not all, mitotic defects in TGCs and hepatocytes caused by E2f7/E2f8 deficiency.
Loss of cyclin A2 reinstates a G2/M block and polyploidy in
E2f7/E2f8 -deficient cells participates in driving TGC differentiation and endocycles by inhibiting Cdk1 function 37 . However, we failed to detect any measurable change in p57 KIP2 mRNA or protein levels that might underlie the phenotype of E2f7/E2f8-deficient TGCs or hepatocytes (Supplementary Fig.  S6d ). Given that cyclin A activity is critical for G2/M progression by regulating the APC (also known as the cyclosome) 38 (Fig. 7c,d ).
In summary, inhibiting the transcriptional network that signals G2/M progression (by E2f1 inactivation) or interfering with the mitotic machinery (by Ccna1/Ccna2 inactivation) re-established a mitotic block and reinstated higher levels of polyploidy in E2f7/E2f8-deficient cells.
DISCUSSION
In multi-cellular organisms there exists diversity in the kinetics and composition of cell cycles and, presumably, in the mechanisms that regulate them. The endocycle is commonly used in flies and plants and, hence, more is known about how they are controlled in these organisms than in mammals [40] [41] [42] [43] [44] [45] . The balanced action of the E2F activator (dE2f1) and repressor (dE2f2) in Drosophila is critical for the tight regulation of cyclin E expression and successful completion of S phase in mitotic and endocycling cells 21, 42, 43 . Although E2Fs are also involved in controlling endocycles in plants, their role seems to be different from in mammals. For example, the atypical E2Fe repressor in Arabidopsis is required to prevent endocycles 44 , whereas we show that the atypical E2F7 and E2F8 family members in mice promote endocycles. A comparison of the regulation of how atypical E2Fs are expressed during development and identification of their direct targets might shed light on these differences. In summary, our present work exposes an intricate E2F network involving balanced and antagonistic activities of canonical E2F activators (E2F1-3) and atypical E2F repressors (E2F7-8) that controls mammalian endocycles. Perhaps the most pronounced manifestation of altering the balance in the E2F network is the ectopic mitosis and karyokinesis observed in E2f7/E2f8-deficient TGCs.
The results presented here expose two distinct arms of the E2F network, one arm involving canonical activators (E2F1-3) and a second involving atypical repressors (E2F7/E2F8), that converge to antagonistically regulate a common gene expression program critical for mammalian endocycles in vivo. A similar antagonistic role for E2F activators and atypical repressors seems to be at play in the control of a distinct program that is critical for mitotic cell cycles during placental development 32 . As loss of E2f4 or E2f5 in mice [12] [13] [14] did not seem to affect the polyploidization of TGCs and hepatocytes ( Supplementary  Fig. S2c and data not shown) we propose that the most ancient E2F repressor arm consisting of atypical E2f7 and E2f8 evolved to specifically regulate variant cell cycles in metazoans in a manner distinct from the function of canonical E2F repressor proteins. One reason for this might be to keep E2F7/E2F8-mediated repression outside the influence of the cyclin-CDK axis. As E2F7/E2F8 DNA-binding activity is independent of DP proteins, atypical repressors would remain unresponsive to CDK-mediated phosphorylation of DP, which negatively regulates the DNA binding and functions of canonical repressors [45] [46] [47] , allowing repression at a time (S/G2) when CDK activity is high. However, the exact molecular mechanism of how canonical activators and atypical repressors coordinate gene expression in endocycling tissues remains obscure.
It has been assumed that polyploidy in mammals, as in flies and plants, is integral to the physiologic functions of placentae and livers. Here we generated mouse models with significantly reduced TGC and hepatocyte ploidy to assess this hypothesis. Surprisingly, TGCs and hepatocytes having significantly restricted ploidy levels seemed to impart placentae and livers, respectively, with adequate organ function to carry animals through embryonic and adult development. Whether altered liver ploidy in mice impacts ageing-related processes such as tumour development remains to be evaluated. In summary, genetic, systems-based and biochemical approaches revealed a fundamental role for the canonical activator and atypical repressor arms of the E2F network in orchestrating mammalian endocycles in vivo.
METHODS
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METHODS
Mouse husbandry and genotyping. All mice were housed in barrier conditions with a 12-h light/dark cycle and had access to food/water ad libitum. Genotyping primers are provided in Supplementary Table S1 .
Feulgen analysis. Placenta/liver sections of 5 µm were treated with 1 N hydrochloric acid and stained with Schiff reagent. Cytoplasm was counterstained with aqueous light green (1%). Nuclear intensity was quantified using ImageJ (http://rsbweb.nih.gov/ij/; ref. 48). TGC ploidy was expressed relative to 2C-4C labrynthine trophoblast cells. For binucleated TGCs, ploidy levels of individual nuclei were summed to derive cumulative ploidy. Hepatocyte ploidy was expressed relative to 2C-4C hepatocytes deficient for E2f7/E2f8. Hepatocyte ploidy was expressed on a per nucleus basis.
Flow cytometry analysis. Nuclei suspensions were obtained from frozen liver tissue as previously described 49 . The total DNA content of a minimum of 30,000 nuclei per liver sample was analysed using LSR II (BD Biosciences). Cell cycle profiles were generated using FlowJo (Tree Star).
Affymetrix analyses. Total RNA was extracted from a minimum of 3 livers per genetic group using TRIzol (Invitrogen). The RNA quality was verified using an Agilent 2100 Bioanalyzer, and samples were submitted to the OSUCCC Microarray Shared Resource facility for biotinylated complementary RNA generation and MOE4302.0 hybridization. A GeneChip Scanner 3000 (Affymetrix) was used for data acquisition. Pre-processing of raw signal intensities was performed using the robust multi-chip average method 50 . BRB-Array Tools 3.8.1 was then used to identify differentially expressed genes 51 . For heat map images, the geometric mean of genes after robust multi-chip average normalization from control liver samples was set as a reference, with colours corresponding to the ratio between expression of genes in mutant samples and the reference. Functional annotation was performed using Ingenuity Pathway Analysis (Ingenuity Systems). Table S3 ). For TGC gene expression analysis, we isolated TGCs from frozen placenta sections using laser capture microdissection (PALM MicroLaser system). Total RNA was then extracted using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems 12204-01). For validation of gene expression changes in the liver (Supplementary Fig. S4a ), the same set of TRIzol-isolated RNA was used in both Affymetrix and NanoString assays. The NanoString data are first normalized to the geometric mean of positive control spike counts in each lane of the cartridge, followed by subtracting the minimum negative control spike counts in each lane to remove the background. Finally, expression of each gene in the code set is normalized with respect to the geometric mean of the housekeeping genes. Heat maps were generated in the same manner as for the Affymetrix gene expression data.
Confocal microscopy and 3D reconstruction. Tissues sections of 70 µm were stained with 1 mM Draq5 (Biostatus) at 4 • C overnight. Sections were examined by confocal laser scanning microscopy (Zeiss LSM 510) at 63× and 0.7× scan zoom. Optical sections with plane-to-plane resolution resolution of 0.40 µm and axial resolution of 0.42 µm were acquired. Four to five non-overlapping regions per placenta were imaged with a field view of 207 µm×207 µm and a depth of 40±2 µm, resulting in a stack of 100 images for each region. This process was identically repeated for liver samples. For 3D reconstruction, the image stacks were processed using Insight Toolkit and ITK-SNAP (ref. 52). Each nucleus was segmented by active contour segmentation using region competition as the stopping criterion 53 . Nuclei of binucleated TGCs were constructed separately and assigned different colours. Only the volumes of individual hepatocyte nuclei were measured.
Transmission electron microscopy. Placentae were fixed/processed following a standard protocol (http://cmif.osu.edu/419.cfm) and embedded in Eponate resin. Placental cross-sections of 70 nm were mounted on copper grids, double stained with uranyl acetate and lead citrate, and observed with a Technai G2 Spirit transmission electron microscope (FEI).
Transient transfections. For HepG2, subconfluent cells were transfected with 1:3 ratio of plasmid DNA/reagent (X-tremeGENE HP DNA Transfection Reagent (Roche)) in 10% FBS RPMI-1640. Cells were collected 48 h after transfection. In one experiment, three 100 cm plates of transfected cells were combined for lysis and sonication as one sample in the ChIP assay. For Rcho-1, transfection conditions were the same as described for HepG2 cells. Rcho-1 cells were maintained as previously described 54 . In one experiment, two 150 cm plates were combined as one sample used in the ChIP. A total of three independent experiments for each cell line was performed. For HEK293 cells, subconfluent cells in 10% FBS DMEM were transfected using calcium phosphate with 25 µg of plasmid DNA expressing wild-type Flag-E2F7/Flag-E2F8 or mutant Flag-E2F7/Flag-E2F8.
Systemic administration of plasmid DNA. Six-week-old wild-type male mice were injected with either sterile PBS or sterile PBS containing 10 µg plasmid DNA through the tail vein following a published protocol 55 . Mice were euthanized by CO 2 asphyxiation 24 h after tail-vein injection. Whole-body perfusion with warm saline was performed using the intracardiac method before excision of the liver, subsequent derivation of a single-celled suspension by passing the perfused tissue through a 40 µm mesh and fixation/processing for ChIP assays.
ChIP assays. For HepG2 and Rcho-1 trophoblast stem cell lines, transfected cells were crosslinked in growth media containing 1% formaldehyde followed by neutralization with 1.25M glycine. The cytoplasmic fraction was discarded (cytoplasmic lysis buffer: 5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP40 and fresh protease inhibitors). Nuclear lysates were collected by incubating the nuclei pellet in lysis buffer containing 50 mM Tris at pH 8.0, 10 mM EDTA, 0.3% SDS and a fresh cocktail of protease/phosphatase inhibitors. Sonicated chromatin (∼100-300 base pairs (bp)) was incubated with 10 µg of anti-Flag mouse monoclonal antibodies (Sigma F1804) or normal mouse IgG (Santa Cruz sc-2025) at 4 • C overnight. Antibody-protein-DNA complexes were recovered by the addition of 50% protein G agarose slurry (Millipore 16-266) pre-cleared with 10 mg ml −1 transfer RNA and 10 mg ml −1 BSA. De-crosslinking was performed at 65 • C overnight with periodic agitation. Recovered DNA was purified using the Qiagen PCR extraction kit. ChIP assays used 5% of input DNA as the standard for 'relative occupancy' and 2 µl of eluted DNA from immunoprecipitated samples for quantitative rtPCR with gene-specific primers and SYBR green (BioRad 170-8880). For HEK293 cells, the EZ-CHIP assay kit (Millipore 17-371) was used following the manufacturer's instructions. Sonicated chromatin was incubated with 2 µg of anti-Flag antibodies (Sigma F1804) or normal mouse IgG (Santa Cruz sc-2025) at 4 • C overnight. Antibody-protein-DNA complexes were recovered by the addition of salmon sperm DNA/protein G agarose slurry (Millipore 16-201). Immunoprecipitated DNA fractions were de-crosslinked at 65 • C overnight and purified using QIAquick columns (QIAGEN). Quantitative rtPCR was performed as above except 1% input was used. All quantitative rtPCRs were performed in triplicate using the following conditions: 1 cycle at 95 Immunoblot assays. Whole-cell lysates were prepared from lysis of HepG2 and Rcho-1 trophoblast stem cells in a standard radioimmunoprecipitation buffer containing a freshly diluted cocktail of protease and phosphatase inhibitors. For preparation of liver lysates, frozen tissue (∼100 mg) was thawed on ice followed by homogenization in radioimmunoprecipitation buffer and then centrifugation at maximum speed for 15 min in 4 • C. Total protein concentration was measured using the Bio-Rad Protein Assay kit (BioRad 500-0006). Denatured samples were separated in 8-10% SDS-polyacrylamide gels, transferred onto PDVF membranes, blocked in 5% milk-PBS solution and incubated overnight in 4 • C with the following primary antibodies: anti-E2F3 1:5,000 (Santa Cruz sc-878x), anti-Flag 1:1,000 (Sigma F1804), anti-tubulin 1:5,000 (Sigma T6199) and anti-HSP70 1:5,000 (BD Transduction Laboratories 610608). HRP-conjugated species-specific secondary antibodies were applied to membranes followed by detection with the SuperSignal West Femto kit (Thermo Scientific 34095).
Immunohistochemistry and immunofluoresence microscopy. After antigen retrieval using Target Retrieval Solution (DAKO S1699), 5 µm deparaffinized sections of placenta or liver tissues were incubated with primary antibodies at 4 • C overnight against E2F7 1:100 (Abcam ab56022), E2F8 1:50 (polyclonal against residues 576-595 of murine E2F8), BrdU 1:100 (DAKO MO-0744), Ki67 1:100 (BD Pharmingen 550609), phospho-histone 3 (Ser10) 1:100 (Millipore 06-570), cyclin A2 1:100 (Santa Cruz sc-596), cyclin B1 1:100 (Santa Cruz sc-752), E-cadherin 1:100 (Abcam ab53033), p57Kip2 1:100 (Santa Cruz sc-8298; refs 56,57) and placental lactogen 1:200 (PL-1, F. Talamantes). TGCs in M phase (Fig. 2h) were identified by detecting P-H3 or the lineage-specific PL-1 protein. For immunofluorescence signal detection, fluorophore-conjugated secondary antibodies were applied to the slides. For immunohistochemistry, the VECTASTAIN ABC system was used (Vector Laboratories).
BrdU incorporation assays. Pregnant females (E10.5) received a single intraperitoneal injection of BrdU (Sigma B5002) in sterile PBS at 100 µg g −1 body weight 1 h before being euthanized for collection of placentae. Deparaffinized tissue sections of 5 µm were used for BrdU detection after incubation in 2N HCl and DOI: 10.1038/ncb2595 neutralization with 10 mM sodium borate (pH 8.0). Primary antibody was then applied overnight. pIpC injections. Six-week-old mice received 5 intraperitoneal injections of 250 µg of pIpC (Sigma P1530) dissolved in sterile PBS every alternate day. Mice were euthanized 24 h after the last injection, and their livers were collected for flow cytometry and microarray analyses.
Carbon tetrachloride injection. Six-month-old mice received a single intraperitoneal injection of 10% carbon tetrachloride (Sigma 319961) dissolved in corn oil. Mice were euthanized at 0, 24, 48, 60 and 168 h (when liver regeneration is complete in rodents 58 ) post-injection. Mice were administered an intraperitoneal injection of BrdU solution (100 µg g −1 body weight) to label hepatocytes in S phase of the cell cycle 1 h before being euthanized.
Tamoxifen induction of cre. Tamoxifen chow (Teklad Lab Animal Diets, Harlan Laboratories) was prepared by mixing 3 kg of irradiated standard chow with 1 g tamoxifen (Sigma T5648). For pre-weaning induction of cre, 7-day-old pups and their mother were switched from regular to tamoxifen chow for 1 week. After 1 week, they were again fed regular chow until weaning and up to time of euthanization (age 2 months). For post-weaning induction of cre, pups were weaned from their mother at age 21 days and maintained on tamoxifen chow starting from age 28 days up to age 2 months. Tamoxifen chow was stored in the dark at 4 • C and changed weekly. It was provided to mice at 40-80 mg kg −1 body weight 59 .
X-gal staining. OCT-embedded placentae were sectioned and fixed in 0.2%
PBS-glutaraldehyde solution (1.25 mM EGTA at pH 7.3 and 2 mM MgCl 2 ). Sections were rinsed with wash buffer (2 mM MgCl 2 , 0.01% sodium deoxycholate and 0.02% IGEPAL CA-630 (Sigma I8896)) and stained in LacZ solution (4 mM potassium ferricyanide, 4 mM potassium ferrocyanide and 1 mg ml −1 X-gal in wash buffer) at 37 • C overnight with protection from light. Nuclear Fast red was used as a counterstain.
E2F-binding-site analysis.
Promoter sequences (−3000 bp ∼+2000 bp) of genes antagonistically regulated by E2F1-3 and E2F7/E2F8 were obtained from the UCSC genome browser (http://genome.ucsc.edu/). Consensus E2F-binding sites were identified using TFSearch (http://www.cbrc.jp/research/db/TFSEARCH.html).
Statistical analyses. Binucleated TGCs, as a percentage of a minimum of 143 total
TGCs assessed in each genetic group, were quantified in confocal images using the LSM image browser (Zeiss). All other immunohistochemistry/immunofluorescencemicroscopy-associated quantification of TGCs/hepatocytes was performed using Metamorph 6.1 in photomerged images (placenta) or 5-7 random images (liver) acquired at 40× from a minimum of three sections per sample. The results are reported as an average percentage ± s.d. of positive cells in the number (n) of control and mutant samples analysed. Flow cytometry profiles (for example, Fig. 3f ) are representative of a minimum of three independent experiments per genotype and age group. Flow cytometry results are reported as an average percentage ± s.d. of nuclei with a certain DNA content out of a minimum of 30,000 nuclei gated per sample in n control and mutant samples analysed. Pairwise comparisons were evaluated by two-tailed Student's t -tests, whereas multiple comparisons were evaluated by one-way analysis of variance (ANOVA). When appropriate, P values were adjusted by the Holm's method within each ploidy category.
Accession numbers. The gene expression microarray data generated in this study can be found in GEO using accession numbers GSE32353, GSE32354 and GSE32355. Heat shock protein 70 (Hsp70) was used as loading control. Note reduction in the expression of E2F3 isoforms after weaning. 3wk*, one day post weaning; 123tko MEF, E2f1 -/-;E2f2 -/-;E2f3 f/f mouse embryonic fibroblasts infected with cre-expressing retrovirus. b, 5μm deparaffinized liver sections of 6-month-old (6mo) wildtype mice were processed for the Feulgen method, which consisted of hydrolyzing sections in 1N HCl followed by staining with the Schiff reagent. Quantification of nuclear intensity using microspectrodensitometry (ImageJ) showed significant hepatocyte nuclei populations at 8C and 16C ploidy levels, and approximately 5% of nuclei with 32C ploidy (left bar graph). Concordantly, flow cytometry (right) of 6mo wildtype livers showed polyploid nuclei populations of 8C and 16C. Only mono-nucleated hepatocytes were selected for Feulgen analysis, which was subsequently employed to determine TGC ploidy throughout the study. c, E9. Figure S3 E2F8 is the major regulator of hepatocyte endocycles, and E2f7/ E2f8 deficient hepatocytes regenerate following carbon tetrachlorideinduced parenchyma depletion. a, NanoString analysis of liver-specific expression of atypical E2f repressors demonstrating a transient peak in post-natal E2f8 expression that coincides with the time of weaning. Total RNA from n=2 wildtype livers analyzed at each time point. b, Percent hepatic mass analysis in weaning age (3wk), adult (2-6mo) and aged (12mo) livers demonstrating similar measurements in all age groups and genotypes that were assessed. n, number of livers analyzed per genotype and age group. c, Representative H&E liver sections from aged (12-15mo) E2f7 +/+ ;E2f8 +/+ (control), E2f7 -/-;E2f8 +/+ (7ko) and E2f7 +/+ ;E2f8 -/-(8ko) mice. Hepatocytes lacking E2f8 show dramatic reductions in both cellular and nuclear size, consistent with the lack of endocycles. Scale bar, 15μm. d, Flow profiles of liver nuclei suspension from mice as in Supplementary Fig.  3c . Livers from 8ko mice, unlike from control or 7ko mice, do not contain highly polyploid hepatocytes. e-f, Quantification of S phase (BrdU) and M phase (P-H3) positive hepatocytes at 48 and 60 hours after mice received a single intraperitoneal injection of 10% solution of carbon tetrachloride (CCl 4 ), which causes fulminant hepatic necrosis followed by regeneration. In this model, shortly after chemical-induced death of tissue, remaining hepatocytes are mobilized to synchronously re-enter the cell cycle and contribute to parenchyma regeneration. At the time of injection, mice were 6 months of age. Red arrows point to BrdU-negative hepatocytes in e, and hepatocytes in M phase in f. n, number of livers analyzed per genotype and time point. Scale bar, 5μm. g, Percent hepatic mass measurements at different time points after CCl 4 Figure S4 E2F8 function is dispensable in endocycle control after weaning. a, Representative H&E liver sections of 2-month-old E2f8 f/f and SAcreER T2 ;E2f8 f/f mice fed a tamoxifen diet two weeks before weaning (+Tam 7d.) and one week after weaning (+Tam 28d.). Weaning age, 21 days after birth. Scale bar, 15μm. b, Representative flow profiles of liver nuclei suspension from mice as in Supplementary Fig. 4a . Note that loss of E2f8 in the liver after weaning (SA-creER T2 ;E2f8 f/f , +Tam 28d.) resulted in no significant change in ploidy distribution relative to control tissues (E2f8 f/f , +Tam 7d.). c, Flow cytometry of liver nuclei from 2-month-old E2f8 f/f and SA-creER T2 ;E2f8 f/f mice fed a tamoxifen diet two weeks before weaning, n=3 per genetic group analyzed. Two-tailed Student T-Test, * p≤0.05. h, Flow cytometry of liver nuclei from 2-month-old E2f8 f/f and SA-creER T2 ;E2f8 f/f mice fed a tamoxifen diet one week after weaning, n=3 per genetic group analyzed. Data in c-d reported as average ± SD.
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Array Nano Array Nano Array Nano n=4 n=4 n=4 n=4 n=4 n=4 Fig. 4d) . h, The promoters of genes antagonistically regulated by E2F activators and atypical E2F repressors were screened for the presence of E2F binding sites. The analyzed region spanned from 3.0kb upstream of the predicted transcriptional start site (TSS) to 2.0kb downstream of TSS. Of the approximately 700 genes included in this analysis, 580 contained E2F binding sites within the promoter region examined. Of the 580 genes, 45% had just one E2F binding site that might be competitively bound by either E2F activators or repressors at any given time to dictate transcriptional output. Data in d-f reported as average ± SD. Supplementary Fig. 6b legend. There was a significant reduction in the proportion of 178tko TGCs undergoing karyokinesis relative to 78dko TGCs, as well as significant decreases in the fraction of BrdU-and CycB1-positive 178tko TGCs. 
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